Sie sind auf Seite 1von 47

Y  

 




Y



  
   Y


   


Pharma

VISION

To bring colours of joy in the life


of people for a healthier tomorrow
Y  

 
PREFACE

  



 
 
 
   
   
  
 
      


 

ë  

 
 

ECHANIS OF ACTION

      


 
 
      
   
 

     
   

  !

  "

# !$%
  &

 
 
  
   
     




    

 

   !$ 
'    (    
      
  
      
   
    
      
 
 
 
"
PHARACOKINETICS

Y


)*+*,
A -
   

    +


  
D  !!Y

 




 

.  /
E
 Indications`0
   
  
    
  

  

 Contraindication`1

  " 
  
 Adverse Reaction `
 

 

 
  
  

 
PRODUCT PRESENTATION

Ô 


    -eramet -R `2** ***
Ô For 500 mg
2**. *   
*     .
** . 3 

Ô For 1000 mg
***. *   
*     .
** . 3 
STORAGE

 O 
 
 #*2 % 

  
  

 

   

ORG ANALYSIS

]  




"4 5+*2/ 
  

  5,
] 0

"4  2  /
6
 4+,
] 
 
  4  *+22/
6
 4,

"O
47*,
ORG ANALYSIS

 6
   
"4 88 /

" 
48,
6
 4 8,
ORG ANALYSIS
Total Anti Diabetic market is Rs 1518.18 Cr
Ant diabetics Val in Cr arket Growth %
share%
  )2+) 7 5
9 *+22) 75 
O  
:  5+52 52 8
O  
)58*  8
  
 *   7
etformin 99.17 10 19
-
&  +) * *

- 77 ) 2 55
-
& :  282) + 2
-
& :    
527 +
  825 5
 +5 8
PRESCRIPTION ANALYSIS
PRESCRIPTION ANALYSIS

       


   


   
PRESCRIPTION ANALYSIS

) .    

!       
 
 
 
  *7
STRENGTH OPPORTUNITY

First line drug for the treatment of Lucrative market segment.


type 2 diabetes particularly in
overweight and obese people.
Best choice for people with heart
failure
Once daily dose
Less gastrointestinal side effects

THREAT WEAKNESS
Late entry.
Other combination drugs of
metformin
Other oral hypoglycemic agents
SALES
FORECASTING
2
O
  
" - #,%
#   
#,%
  %
*88 **

   * *

5 2)   5*

ë  
2
2**#+*,% ***#)*,%

28
 )*


 7 
 )7


5 8
 +

BRAND STRATEGY
OBJECTIVE

† Shortterm 3  
 ;
; 
**8

" 
  ,

† Long term 3  


  
   
* 2
 CUSTOER SEGENT- 0
    
/ 
! 
     

/
    

 ARKET SEGENT-
†   0
     
    /! 
/
   
† /
  0
    
    /! 
/
   
† /
 0
    
    /! 
/
   
DOCTOR CLASSIFICATION

0/O     /1 OO /1 OO


0/O
-      2** 2** 8** **

/
    )*** 2** )** **

0
    )2** 2** ** **

/! 5 )** **** 2*** +)**
u uu

TYPE 2 DIABETES
0/O   /1 OO  /1 OO
#8*,% #72,% #+*,%

-      52* +72 +*

/
    2* *2* +*

0
    2* 52* *

/! 8*** 2* 5)*

 
     )*
SALES FORCE PLANNING
O
   < "  /

!
   0
 /
=0
 = 

) * )*

5** ) * 7***

0  /
  /
  
/

 0 = 0 =  0 =  0  


/
 2*  ** 2***

/
Y +* +* ***

/
/ 5* 5* 8***

 
 )* 8* )***
COUNICATION
USPs of etformin -R

â  
 
   
 

â  
 
  

   
POSITIONING

âFirst line drug for the treatment of type 2 diabetes


particularly in overweight and obese people.

âBest choice for people with heart failure


PRICING
ETFORIN -R

Y   
  

/
  2** O
  5 **,
; ***
   8 **,

- 2** /


  772 55+8,
;

;
 2** 6Y-2   2* *,
; ***  52* *,
PROOTION
UARTERWISE PROOTIONAL INPUTS
UARTER 1 UARTER 2 UARTER 3 UARTER4

-eramet -R 6 -eramet -R  
 1Y1 -eramet -R




Y
     ?@ 1O
Y
   !
  


"
0 
  
 0  0
 
Y
  /  
1Y1
0 
 
  
     > 06 O   /     >
? 
  /  

O
  O
  
 

   
25% ON PROOTION 24.75 LAKH

TOTAL SLAES- 0.99 CR


, *)72
"
O

, *)72
"
1
 
, 87
"
Y
 
, *)72
"

 
2, 5
"

2, 51
"

*, )72
"
O " 
2, *)72
"


+*, )2
"
/
2, 5
"
! 
  
BRAND P&L AND FINANCIAL
SUARY
ETFORIN -R

Price Calculation 500mg 1000mg

Excise Duty etformin -R RP 18.50 23.50


2** *** VAT
(4%) 1 1
! 2* 52*
+2#,%  2 17.50 22.50
ED (8%) 1 ED (8%) 1 1

16.50 21.50

Discount to retailer 15% 2.5 3


(-ED &
Price to Retailer VAT) 14 18.50
Discount to
Stockist 8% 1 1.5
Price to Stockist (-ED &
(NR) VAT) 13 17
ETFORIN -R 500mg

Price Yr 1 Yr 2 Yr 3
elements
No. of units 4,53,846 5,46,154 7,07,692

NR/ unit Rs 13 Rs 13 Rs 13

Sales 59 lacs 71 lacs 92 lacs

Cost of goods 23.6lacs 28.4 lacs 36.8 lacs

G 35.4 lacs 42.6 lacs 55.2 lacs


G (%) 60% 60% 60%
ETFORIN -R 1000mg

Price Yr 1 Yr 2 Yr 3
elements
No. of units 2,35,294 2,76,471 3,64,706

NR/ unit Rs 17 Rs 17 Rs 17

Sales 40 lacs 47 lacs 62 lacs

Cost of goods 16 lacs 18.8 lacs 24.8 lacs

G 24 lacs 28.2 lacs 37.2 lacs


G (%) 60% 60% 60%
FINANCIAL SUARY
Yr1 Yr 2 Yr 3
Sales 0.99 Cr 1.18 Cr 1.54 Cr
NR/ unit Rs 15 Rs 15 Rs 15
No. of units 6,60,000 7,86,666 10,26,666
Cost of goods 0.40 0.47 0.62
GC 0.59 0.71 0.92
GC% 60% 60% 60%
Promotional 0.25 Cr(25%) 0.24 Cr (20%) 0.23 Cr (15%)
exp
arketing 0.08 Cr (8%) 0.12 Cr(10%) 0.18 Cr(12%)
Distribution 0.05(5%) 0.07(6%) 0.12(8%)
Selling 0.1(10%) 0.18(15%) 0.3(20%)
PBT 0.51 Cr 0.57 Cr 0.71 Cr
DATE ACTIVITIES PLANNED
7th December 2008 1
 
 "
 

 
" 


 


   
18th February 2009 !   


 
6th arch 2009 !   
 
  
 

20th arch !    

 " 
1st April !    



7thApril 2009
Launch of

-ERAET -R
   
A B   CCC